Cargando…

Partial Stereotactic Ablative Boost Radiotherapy in Bulky Non-Small Cell Lung Cancer: A Retrospective Study [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024795/ https://www.ncbi.nlm.nih.gov/pubmed/32103986 http://dx.doi.org/10.2147/OTT.S241316

Ejemplares similares

Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study
por: Bai, Yun, et al.
Publicado: (2018)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Application of Radiosensitizers in Cancer Radiotherapy [Corrigendum]
Publicado: (2021)

Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum]
Publicado: (2021)

Corrigendum to: Fear boosts the early neural coding of faces
por: Turano, Maria Teresa, et al.
Publicado: (2017)

Proton-Based Stereotactic Ablative Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer
por: Grant, Jonathan D., et al.
Publicado: (2014)

Corrigendum to “Classification of Non-Small Cell Lung Cancer Using Significance Analysis of Microarray-Gene Set Reduction Algorithm”
por: Zhang, Lei, et al.
Publicado: (2018)

Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer [Corrigendum]
Publicado: (2017)

Corrigendum to “Probing for Sparse and Fast Variable Selection with Model-Based Boosting”
por: Thomas, Janek, et al.
Publicado: (2018)

Efficacy and safety of apatinib treatment for gastric cancer, hepatocellular carcinoma and non-small cell lung cancer: a meta-analysis [Corrigendum]
Publicado: (2019)

Corrigendum to “Left Atrial Anatomy Relevant to Catheter Ablation”
por: Sánchez-Quintana, Damián, et al.
Publicado: (2020)

Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer
por: Oweida, Ayman, et al.
Publicado: (2017)

Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2023)

Complete metabolic response after Partially Ablative Radiotherapy (PAR) for bulky retroperitoneal liposarcoma: A case report
por: Medici, Federica, et al.
Publicado: (2023)

Corrigendum to: Epicardial ablation in genetic cardiomyopathies: a new frontier
Publicado: (2019)

Corrigendum to “PIAS1-FAK Interaction Promotes the Survival and Progression of Non–Small Cell Lung Cancer” [Neoplasia 18 (2016) 282-293].
por: Constanzo, Jerfiz D., et al.
Publicado: (2016)

The role of maintenance therapy in the treatment of elderly non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials [Corrigendum]
Publicado: (2018)

Detection of second primary lung cancers on surveillance imaging following stereotactic ablative radiotherapy for non-small cell lung cancer
por: Aldin, Muhtada Kamal, et al.
Publicado: (2022)

Corrigendum to “Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease”
por: Kawabori, Masahito, et al.
Publicado: (2021)

Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea
por: Song, Sanghyuk, et al.
Publicado: (2017)

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer
por: Yang, Dan, et al.
Publicado: (2020)

A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer
por: Akanda, Zarique Z., et al.
Publicado: (2021)

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy [Corrigendum]
Publicado: (2022)

[Corrigendum] Wnt-signaling and apoptosis after neoadjuvant short-term radiotherapy for rectal cancer
por: Gassler, Nikolaus, et al.
Publicado: (2023)

Corrigendum to: Brigatinib dose rationale in anaplastic lymphoma kinase–positive non‐small cell lung cancer: Exposure–response analyses of pivotal ALTA study
Publicado: (2021)

Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment [Corrigendum]
Publicado: (2022)

[Corrigendum] METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression
por: Zhang, Yongxi, et al.
Publicado: (2023)

Corrigendum to “Recurrent Syncope Associated with Lung Cancer”
por: Zhang, Dingguo, et al.
Publicado: (2016)

Corrigendum: Partial second toe pulp free flaps in early childhood
por: Hong, Min Ki, et al.
Publicado: (2021)

Corrigendum to “APPBP2 enhances non-small cell lung cancer proliferation and invasiveness through regulating PPM1D and SPOP” [EBioMedicine (2019)]
por: Gong, Huiyuan, et al.
Publicado: (2019)

Corrigendum to “Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach”
Publicado: (2021)

[Corrigendum] Epigallocatechin‑3‑gallate inhibits nicotine‑induced migration and invasion by the suppression of angiogenesis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells
por: Shi, Jingli, et al.
Publicado: (2023)

Long Non-Coding RNA PVT1 Regulates BAMBI to Promote Tumor Progression in Non-Small Cell Lung Cancer by Sponging miR-17-5p [Corrigendum]
Publicado: (2020)

Corrigendum to: Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study
Publicado: (2016)

Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
por: Lu, Shao-Lun, et al.
Publicado: (2016)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Decitabine reverses TGF-β1-induced epithelial–mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis [Corrigendum]
Publicado: (2017)

Integrative Gene Expression Profiling Reveals That Dysregulated Triple microRNAs Confer Paclitaxel Resistance in Non-Small Cell Lung Cancer via Cotargeting MAPT [Corrigendum]
Publicado: (2020)

Corrigendum to: UNC13B variants associated with partial epilepsy with favourable outcome
Publicado: (2021)

pH-Responsive Artesunate Polymer Prodrugs with Enhanced Ablation Effect on Rodent Xenograft Colon Cancer [Corrigendum]
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b8pis84kmb7vh5774f7cvjkb7j